UKIPO appoints permanent chief executive

Interim CEO becomes permanent | Appointee “brings broad leadership experience and deep knowledge of the IPO” | Appointment “concludes a period of change at IPO”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

UKIPO rejects Novartis’s TM opposition attempt

18 June 2020 Switzerland-based Novartis has failed to convince the UK Intellectual Property Office that a trademark applied-for by Boston Healthcare should not be registered.

Biotechnology

CIPA and UKIPO join forces to change misleading Brexit advice

3 February 2020 The UK Intellectual Property Office and the Chartered Institute of Patent Attorneys have worked together to ensure changes are made to “misleading” advice issued by the EU’s Community Plant Variety Office.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

UKIPO appoints permanent chief executive

More on this story

Editor's picks

Editor's picks

More features